YGU was founded in 2022, at the moment Thailand entered a new era of cannabis legalization. From the beginning, the goal was clear: to create cannabis products rooted in Thailand’s culture while meeting the highest medical expectations.

As Thailand’s legal framework continues to evolve, YGU has committed to evolving alongside it — aligning every process, product, and standard with the country’s medical direction rather than chasing short-term trends.

YGU curates cannabis specifically for Thailand’s medical market, placing patients, safety, and consistency at the center of every decision.

Only GACP-certified flower is used, supported by full Certificates of Analysis. All indoor flower is carefully selected and procured within one month to ensure freshness and quality.

For terpene formulation, YGU works exclusively with FDA-certified, consumable botanical terpenes produced in the United States — natural, plant-derived, and never synthetic — chosen for both safety and reliability.

Across sourcing, formulation, and quality control, YGU applies strict internal standards so that every product is clean, compliant, reproducible, and worthy of medical use.

YGU speaks to regulators, retail partners, and consumers with the same philosophy: transparency, responsibility, and long-term trust.

The ambition is simple — to build the most trusted cannabis products in Thailand.